David Martin, MD
Plastic and Reconstructive Surgery · Dallas, TXNPI 1841378536
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (51.4%), food and beverage and other — rather than concentrated in one kind of arrangement. AbbVie accounts for 69.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2019 at $3,092 and has fallen 74.9% since, to $776 in 2025.
Across 50 payments — averaging $109.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Johnson & Johnson$500
- Regeneron Healthcare Solutions, Inc.$434
- Stryker$312
- Motiva USA, LLC$141
- Acera Surgical, Inc.$109
- plus $189 from 5 others
What the payments were for
- Food & beverage$2,15439%
- Gifts$2,80451%
- Other$5009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $3,773 |
| Johnson & Johnson | 1 | $500 |
| Regeneron Healthcare Solutions, Inc. | 11 | $434 |
| Stryker | 3 | $312 |
| Motiva USA, LLC | 1 | $141 |
| Acera Surgical, Inc. | 1 | $109 |
| TELA Bio, Inc. | 1 | $85 |
| Mentor Worldwide LLC | 1 | $42 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Vertex | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NATRELLE$3,077
- NATRELLE SALINE-FILLED BREAST IMPLANTS$290
- LIBTAYO$235
- MAKO$166
- Motiva Implant Matrix$141
- ACCOLADE$126
- Restrata Wound Matrix$109
How this compares
$5,458 in reported general payments places this provider in the 65th percentile of 378 plastic and reconstructive surgery providers in Texas.
See all plastic and reconstructive surgery providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 12 | $622 |
| Cephalexin | 11 | $35 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Dallas
- Ben TittleDallas$73K
- Jennifer KargelDallas$17K
- Richard HaDallas$17K
- Solomon AzouzDallas$16K
- Bradley HubbardDallas$14K
- Jeffrey KenkelDallas$12K
- Aldona SpiegelHouston$759K
- Charles ButlerHouston$227K
- Michael KlebucHouston$204K
- Joshua LemmonRichardson$118K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.